UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934*
Tandem Diabetes Care, Inc. |
(Name of Issuer)
Common Stock, $0.001 par value |
(Title of Class of Securities)
875372104 |
(CUSIP Number)
February 9, 2018 |
(Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ | Rule 13d-1(b) | |
☒ | Rule 13d-1(c) | |
☐ | Rule 13d-1(d) |
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No . | 875372104 | Page 2 of 10 |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS 47-4771203 |
|||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ (b) ☐ | ||
3 | SEC USE ONLY | |||
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
NUMBER OF BENEFICIALLY EACH PERSON |
5 |
SOLE VOTING POWER 0 |
||
6 |
SHARED VOTING POWER 4,500,000 |
|||
7 |
SOLE DISPOSITIVE POWER 0 |
|||
8 |
SHARED DISPOSITIVE POWER 4,500,000 |
|||
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,500,000 |
|||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES | ☐ | ||
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.08% |
|||
12 |
TYPE OF REPORTING PERSON PN |
|||
CUSIP No . | 875372104 | Page 3 of 10 |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS 35-2538554 |
|||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ (b) ☐ | ||
3 | SEC USE ONLY | |||
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
NUMBER OF BENEFICIALLY EACH PERSON |
5 |
SOLE VOTING POWER 0 |
||
6 |
SHARED VOTING POWER 4,500,000 |
|||
7 |
SOLE DISPOSITIVE POWER 0 |
|||
8 |
SHARED DISPOSITIVE POWER 4,500,000 |
|||
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,500,000 |
|||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES | ☐ | ||
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.08% |
|||
12 |
TYPE OF REPORTING PERSON HC |
|||
CUSIP No . | 875372104 | Page 4 of 10 |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS 46-3521994 |
|||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ (b) ☐ | ||
3 | SEC USE ONLY | |||
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
NUMBER OF BENEFICIALLY EACH PERSON |
5 |
SOLE VOTING POWER 0 |
||
6 |
SHARED VOTING POWER 4,734,238 |
|||
7 |
SOLE DISPOSITIVE POWER 0 |
|||
8 |
SHARED DISPOSITIVE POWER 4,734,238 |
|||
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,734,238 |
|||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES | ☐ | ||
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.61% |
|||
12 |
TYPE OF REPORTING PERSON IA |
|||
CUSIP No . | 875372104 | Page 5 of 10 | ||||||
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS |
|||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ (b) ☐ | ||||||
3 | SEC USE ONLY | |||||||
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION United State of America |
|||||||
NUMBER OF BENEFICIALLY EACH PERSON |
5 |
SOLE VOTING POWER 0 |
||||||
6 |
SHARED VOTING POWER 4,859,238 |
|||||||
7 |
SOLE DISPOSITIVE POWER 0 |
|||||||
8 |
SHARED DISPOSITIVE POWER 4,859,238 |
|||||||
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,859,238 |
|||||||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES | ☐ | ||||||
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.89% |
|||||||
12 |
TYPE OF REPORTING PERSON IN |
|||||||
CUSIP No. | 875372104 | Page 6 of 10 |
Item 1(a). | Name of Issuer: | ||
Tandem Diabetes Care, Inc. | |||
Item 1(b). | Address of Issuer’s Principal Executive Offices: | ||
11075 Roselle St., San Diego, CA 92121 | |||
Item 2(a). | Name of Person Filing: | ||
This Schedule 13G is being jointly filed by the following:
First Light Focus Fund, LP (the “Fund”) First Light Focus Fund GP, LLC (the “General Partner”) First Light Asset Management, LLC (the “Manager”) Mathew P. Arens (“Mr. Arens”) | |||
(1) The Fund is the direct holder and the beneficial owner of the Issuer’s shares of common stock, par value $0.001 per share (“Shares”) reflected in Item 4 below. (2) The General Partner is deemed to be a beneficial owner of Shares held directly by the Fund because it is the sole general partner of the Fund. The General Partner does not own any Shares for its own account, and disclaims beneficial ownership of the Shares reported herein. (3) The Manager is deemed to be a beneficial owner of the Shares reflected in Item 4 below because it (i) acts as investment adviser to the Fund and (ii) acts as investment adviser to certain separately managed accounts that are the direct holders of an aggregate amount of 234,238 Shares. The Manager does not own any Shares for its own account, and disclaims beneficial ownership of the Shares reported herein. (4) Mr. Arens both (i) directly holds 125,000 Shares held in a joint spousal account for which he shares control, and (ii) is deemed to be the beneficial owner of the Shares with respect to which the Manager has investment power because Mr. Arens controls the Manager in his position as the managing member and majority owner of the Manager. Mr. Arens does not own any of the Shares reported under the foregoing clause (ii), and disclaims beneficial ownership of such Shares.
| |||
Item 2(b). | Address of Principal Business Office or, if None, Residence:
| ||
Each of the reporting persons identified in Item 2(a) has its principal business office at:
3300 Edinborough Way, Suite 201, Edina, MN 55435 | |||
Item 2(c). | Citizenship: | ||
First Light Focus Fund, LP – Delaware limited partnership First Light Focus Fund GP, LLC – Delaware limited liability company First Light Asset Management, LLC – Delaware limited liability company Mathew P. Arens – United States citizen | |||
Item 2(d). | Title of Class of Securities: | ||
Common Stock, $0.001 par value | |||
Item 2(e). | CUSIP Number: | ||
875372104 | |||
Item 3. | If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a: | ||
(a) | ☐ | Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). | |
(b) | ☐ | Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). | |
(c) | ☐ | Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). | |
(d) | ☐ | Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
(e) | ☐ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
CUSIP No . | 875372104 | Page 7 of 10 | |||||
(f) | ☐ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | |||||
(g) | ☐ | A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G); | |||||
(h) | ☐ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |||||
(i) | ☐ | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); | |||||
(j) | ☐ | Group, in accordance with §240.13d-1(b)(1)(ii)(J). | |||||
Item 4. | Ownership. | ||||||
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. | |||||||
(a) | Amount beneficially owned: | ||||||
First Light Focus Fund, LP – 4,500,000 First Light Focus Fund GP, LLC – 4,500,000 First Light Asset Management, LLC – 4,734,238 Mathew P. Arens – 4,859,238 | |||||||
(b) | Percent of class:1 | ||||||
First Light Focus Fund, LP – 10.08% First Light Focus Fund GP, LLC – 10.08% First Light Asset Management, LLC – 10.61% Mathew P. Arens – 10.89% | |||||||
(c) | Number of shares as to which such person has: | ||||||
(i) | Sole power to vote or to direct the vote | ||||||
First Light Focus Fund, LP – 0 First Light Focus Fund GP, LLC – 0 First Light Asset Management, LLC – 0 Mathew P. Arens – 0 | |||||||
(ii) | Shared power to vote or to direct the vote | ||||||
First Light Focus Fund, LP – 4,500,000 First Light Focus Fund GP, LLC – 4,500,000 First Light Asset Management, LLC – 4,734,238 Mathew P. Arens – 4,859,238 | |||||||
(iii) | Sole power to dispose or to direct the disposition of | ||||||
First Light Focus Fund, LP – 0 First Light Focus Fund GP, LLC – 0 First Light Asset Management, LLC – 0 Mathew P. Arens – 0 | |||||||
(iv) | Shared power to dispose or to direct the disposition of | ||||||
First Light Focus Fund, LP – 4,500,000 First Light Focus Fund GP, LLC – 4,500,000 First Light Asset Management, LLC – 4,734,238 Mathew P. Arens – 4,859,238 | |||||||
|
______________________________
1 Percentage calculated based on 44,619,404 aggregate shares of common stock issued and outstanding as of February 16, 2018 following the closing of the underwritten public offering of the issuer’s common stock, as reported in the Form 8-K filed by the issuer on February 14, 2018, and as further described in the Rule 424(b)(4) prospectus filed by the issuer on February 9, 2018.
CUSIP No . | 875372104 | Page 8 of 10 |
Item 5. | Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐ | |
Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable | |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not applicable | |
Item 8. | Identification and Classification of Members of the Group. |
Not applicable | |
Item 9. | Notice of Dissolution of Group. |
Not applicable | |
Item 10. | Certification. |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
FIRST LIGHT FOCUS FUND, LP
|
|||
Date: | February 16, 2018 | ||
By: | |||
Name: | Jin K. Lien | ||
Title: | Chief Compliance Officer | ||
FIRST LIGHT FOCUS FUND GP, LLC
|
|||
Date: | February 16, 2018 | ||
By: | |||
Name: | Jin K. Lien | ||
Title: | Chief Compliance Officer | ||
FIRST LIGHT ASSET MANAGEMENT, LLC
|
|||
Date: | February 16, 2018 | ||
By: | |||
Name: | Jin K. Lien | ||
Title: | Chief Compliance Officer | ||
Date: February 16, 2018 |
|||
By: | |||
Name: | Mathew P. Arens | ||
Title: |
CUSIP No . | 875372104 | Page 9 of 10 |
Exhibit A
JOINT FILING AGREEMENT
The Undersigned agree that the statement on Schedule 13G with respect to the common stock of Tandem Diabetes Care, Inc., dated as of February 16, 2018, is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
FIRST LIGHT FOCUS FUND, LP | ||
By: | ||
Name: | Jin K. Lien | |
Title: | Chief Compliance Officer |
FIRST LIGHT FOCUS FUND GP, LLC | ||
By: | ||
Name: | Jin K. Lien | |
Title: | Chief Compliance Officer |
FIRST LIGHT ASSET MANAGEMENT, LLC | ||
By: | ||
Name: | Jin K. Lien | |
Title: | Chief Compliance Officer |
Signature: | ||
Name: | Mathew P. Arens | |